Careful consideration of CT scanning protocols can cut breast radiation burden by 50 percent, according to a new study in the American Journal of Roentgenology.
Careful consideration of CT scanning protocols can cut breast radiation burden by 50 percent, according to a new study in the American Journal of Roentgenology.
The study compared organ doses to the breast, lungs and pelvis using commonly used protocols with an anthropomorphic phantom. Researchers used 64-MDCT with metal oxide semiconductor field effect transistor (MOSFET) detectors in the breast (skin and parenchyma), the lungs, and the upper and lower pelvis.
Researchers found that the highest doses to the breast skin and parenchyma were found with standard thoracic CT protocols (120 kVp, variable 120-320 mA) and the protocol used to assess for pulmonary embolism in the general population (120kVp, variable 200-394 mA), said Diana Litmanovich, MD, of Harvard Medical School in Boston and the study’s lead author. The team found the dose was reduced by more than half when they used a protocol for assessing pulmonary embolism in pregnant or young patients (100 kVP, fixed 200 mA).
The standard thoracic CT and the pulmonary embolism protocols also led to the highest radiation doses to the lung, Litmanovich said. The lung received the highest organ dose regardless of the protocol, while pelvic radiation was low regardless of the protocol, she said.
“Despite efforts to reduce radiation dose, irradiation of the breast and lung remain substantial,” said Litmanovich. “The study emphasizes the need for caution when we are planning our CT protocols.”
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.